Reports for CANDESARTAN CILEXETIL
Ingredient
CANDESARTAN CILEXETIL
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TARO-CANDESARTAN | 32MG | TABLET | Resolved | 2019-05-28 | 2021-01-31 | 85078 |
TARO-CANDESARTAN | 32MG | TABLET | Resolved | 2022-08-25 | 2023-09-26 | 167932 |
ATACAND | 32MG | TABLET | Resolved | 2019-02-06 | 2019-03-14 | 74863 |
ATACAND | 32MG | TABLET | Resolved | 2020-02-10 | 2020-03-26 | 105632 |
ATACAND | 32MG | TABLET | Resolved | 2020-06-10 | 2020-06-26 | 117398 |
TEVA-CANDESARTAN | 32MG | TABLET | Resolved | 2020-01-09 | 2020-06-11 | 102898 |
TEVA-CANDESARTAN | 32MG | TABLET | Resolved | 2020-07-16 | 2020-08-21 | 120476 |
TEVA-CANDESARTAN | 32MG | TABLET | Resolved | 2022-09-30 | 2022-12-22 | 170792 |
TEVA-CANDESARTAN | 32MG | TABLET | Resolved | 2023-01-19 | 2023-04-28 | 181605 |
TEVA-CANDESARTAN | 32MG | TABLET | Resolved | 2023-06-08 | 2023-10-19 | 194154 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
ACT CANDESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65050 | ||
ACT CANDESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65052 | ||
APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 41047 |
APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60331 |
APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60335 |
APO-CANDESARTAN/HCTZ | 12.5MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 41020 |
MYLAN-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-07-03 | 2018-07-04 | 53621 |
APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60313 |
APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60316 |
APO-CANDESARTAN/HCTZ | 25MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-05-03 | 41011 |